Carcinoma, Small Cell: all 103 studies
Page 1 of 2. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)RecruitingNCT07625644Phase 3
- Penfluridol for Relapsed/Refractory Small Cell CancersNot yet recruitingNCT07206563Phase 1/2
- ALG-LungCancerRegistry (SAFRO2202)RecruitingNCT07161882
- Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the CervixEnrolling by invitationNCT06810895
- Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLCNot yet recruitingNCT06672133Phase 3
- A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell CarcinomaNot yet recruitingNCT06478264Phase 2
- AGNOSTIC THERAPY IN A PHASE II SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB IN ASSOCIATION WITH CARBOPLATIN OR CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY EXTENSIVE STAGE - EXTRAPULMONARY SMALL CELL CARCINOMARecruitingNCT06464068Phase 2
- Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLCRecruitingNCT06350162Phase 2
- Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body IrradiationRecruitingNCT06110572Phase 1/2
- Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell CarcinomaRecruitingNCT05760053Phase 2
- Quantifying Systemic Immunosuppression to Personalize Cancer TherapyRecruitingNCT05621837
- Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote MonitoringRecruitingNCT05500391Phase 2
- Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.RecruitingNCT04253145Phase 1/2
- Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior ChemotherapyRecruitingNCT00100256Phase 1/2
- A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsTerminatedNCT05551117Phase 2Results posted
- Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate CancerTerminatedNCT04926181Phase 2Results posted
- Resiliency Among Older Adults Receiving Lung Cancer TreatmentCompletedNCT04229381Not applicableResults posted
- Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung CancerTerminatedNCT03995667Phase 2Results posted
- Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate CancerTerminatedNCT03649841Phase 2Results posted
- M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung CancersCompletedNCT03554473Phase 1/2Results posted
- Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid TumorsTerminatedNCT03366103Phase 1/2Results posted
- PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung CancersCompletedNCT02936323Phase 1/2Results posted
- Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung CancerTerminatedNCT02899728Phase 2Results posted
- Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticActive, not recruitingNCT02721732Phase 2Results posted
- RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)CompletedNCT02489903Phase 2Results posted
- Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell CancersCompletedNCT02487095Phase 1/2Results posted
- Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical CancerCompletedNCT02164461Phase 1Results posted
- Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung CarcinomaTerminatedNCT02034123Phase 1Results posted
- Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT01642251Phase 1/2Results posted
- Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate CancerCompletedNCT01505868Phase 1/2Results posted
- Study of Arsenic Trioxide in Small Cell Lung CancerCompletedNCT01470248Phase 2Results posted
- Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic MalignanciesCompletedNCT01306045Phase 2Results posted
- To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung CancerTerminatedNCT01284348Phase 2Results posted
- Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT01266447Phase 2Results posted
- RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerTerminatedNCT01217411Phase 1/2Results posted
- A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and EtoposideTerminatedNCT00537511Phase 1/2Results posted
- A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and RadiotherapyTerminatedNCT00447421Phase 1/2Results posted
- Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerCompletedNCT00416455Phase 1/2Results posted
- BI 2536 Second Line Monotherapy in SCLCCompletedNCT00412880Phase 2Results posted
- ABI-007 in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00309959Phase 2Results posted
- Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00305942Phase 2Results posted
- Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung CancerCompletedNCT00298896Phase 2Results posted
- Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung CancerCompletedNCT00284154Phase 2Results posted
- Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung CancerTerminatedNCT00265200Phase 2Results posted
- Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung CancerTerminatedNCT00129974Phase 2Results posted
- Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine CancerWithdrawnNCT07328490Phase 1/2
- Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung CancerTerminatedNCT06140407Phase 2
- Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate CancerWithdrawnNCT06094842Phase 1
- Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung CancerWithdrawnNCT05572476Phase 2
- A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung CancerActive, not recruitingNCT05566041Phase 3
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type PatientCompletedNCT05368207Not applicable
- Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung CancerCompletedNCT05304793Not applicable
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- IMFINZI Study in Patients With Extensive Stage Small Cell Lung CancerCompletedNCT04854590
- Impact of Low Muscle Mass in HNC Treated With ImmunotherapyStatus unknownNCT04721184
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsActive, not recruitingNCT04660929Phase 1
- Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT04622228Phase 2
- A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung CancerTerminatedNCT04308785Phase 2
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.CompletedNCT03910660Phase 1/2
- Neoantigen-primed DC Vaccines Therapy for Refractory Lung CancerStatus unknownNCT03871205Phase 1
- Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed ChemotherapyStatus unknownNCT03811379Phase 2
- RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung CancerTerminatedNCT03699956Phase 3
- Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsActive, not recruitingNCT03333616Phase 2
- Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersActive, not recruitingNCT03212404Phase 1
- A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer SpecimensCompletedNCT03092739
- BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung CancerCompletedNCT03083691Phase 2
- Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell CarcinomaCompletedNCT02881125Phase 1
- HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung CancerStatus unknownNCT02736916Not applicable
- Circulating Tumor DNA in Patients at High Risk for Lung CancerTerminatedNCT02715102
- Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLCCompletedNCT02688036Phase 3
- Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung CancerStatus unknownNCT02675088Not applicable
- TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)TerminatedNCT02608411Phase 2
- Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot StudyStatus unknownNCT02366741Not applicable
- Temozolomide as Maintenance Therapy in Small Cell Lung CancerStatus unknownNCT01900951Phase 2
- A Phase I Study of iPS Cell Generation From Patients With COPDCompletedNCT01860898Not applicable
- Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung CancerStatus unknownNCT01635400Phase 2
- Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung CancerCompletedNCT00923884
- Hypofractionated Radiotherapy for Limited Stage Small Cell Lung CancerCompletedNCT00907569Phase 2
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer PatientCompletedNCT00826644Phase 3
- N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing ChemotherapyTerminatedNCT00637624Not applicable
- Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue SarcomaCompletedNCT00580320Phase 1
- Hypofractionated Radiotherapy for Small Cell Lung CancerCompletedNCT00469222Phase 1
- Cone Beam CT Scanning in Lung and Bladder Cancer.CompletedNCT00469066
- Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung CancerCompletedNCT00466232Phase 1
- Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesCompletedNCT00460356
- Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung CarcinomaTerminatedNCT00435578Phase 2
- A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung CancerCompletedNCT00359359Phase 1/2
- Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)TerminatedNCT00324558Phase 2
- Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerCompletedNCT00308529Phase 2
- Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00294931Phase 2
- Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung CancerCompletedNCT00294190Phase 2
- The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyCompletedNCT00270166Phase 3
- Metabolomic Analysis of Lung CancerCompletedNCT00263731
- A Study of Pemetrexed in Small Cell Lung Cancer, Which Has ReturnedCompletedNCT00191750Phase 2
- Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung CancerCompletedNCT00126828Phase 1/2
- Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or MediastinumTerminatedNCT00094978Phase 1